Evercore - Class A opened lower at $291.30, compared with its previous close of $297.59. In the last trading session, the stock traded between $286.74 and $295.93. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Evercore - Class A is now worth
$ 189.15
giving a profit of
$ 89.15 (89.15%)
Note: Past profits do not guarantee future returns.
Rating from 6 Analysts
Today's Change
$-10.38 (-3.49%)
Day High
$295.93
Day Low
$286.74
Day Open
$291.30
Prev Close
$297.59
Volume
1,40,740
1W Return
12.50%
1M Return
11.18%
3M Return
-5.70%
6M Return
-11.39%
1Y Return
-1.81%
Market Cap ($ Mn)
11,046
PE Ratio
16.34
PB Ratio
6.00
PEG Ratio
2.30
ROE
36.78%
ROCE
-
EPS (TTM)
$2.48
1 Week
12.50%
1 Month
11.18%
3 Months
-5.70%
6 Months
-11.39%
9 Months
-19.30%
Evercore appoints Nigel Dawn and Naveen Nataraj as co-presidents
Evercore appoints Nigel Dawn and Naveen Nataraj as Co-Presidents effective January 1, 2027. John S. Weinberg remains Chairman and CEO for at least the next three years. New leadership structure aims to support global expansion and strategic growth.
11 days agoEvercore hires UBS executive to strengthen DACH investment banking
Philip von Malsen-Plessen joins Evercore as senior managing director in Frankfurt. He previously served as vice chairman of global banking EMEA at UBS for nearly 30 years. The hire aims to strengthen Evercore's investment banking presence in the DACH region.
25 days agoEvercore appoints John Pissanos as senior MD in healthcare banking
John Pissanos joins Evercore as senior managing director in healthcare investment banking. Based in London, he will focus on life science tools, diagnostics, and medtech. Brings nearly 15 years of experience, most recently from J.P. Morgan. Move aims to strengthen Evercore's healthcare franchise across EMEA.
1mo agoEvercore Q2 Adj. EPS $2.91 Beats $2.77 Estimate, Sales $1.000B Beat $925.6M
Evercore Inc. delivered record Q2 2026 results, beating analyst estimates for both earnings and revenue. Adjusted EPS came in at $2.91, surpassing the $2.77 consensus, while adjusted revenues reached $999.5 million, exceeding the $925.6 million forecast. The performance was driven by broad-based growth across advisory, underwriting, and wealth management segments.
3mo agoKBW raises Evercore target to $390, UBS at $350
Keefe, Bruyette & Woods and UBS have both raised their price targets for Evercore, with KBW setting a new target of $390 and UBS at $350, reflecting differing views on the stock's potential.
3mo agoEvercore hires Eric Rabinowitz as senior managing director
Evercore has appointed Eric Rabinowitz as a senior managing director in its healthcare investment banking group, based in New York. Rabinowitz brings over 20 years of experience, most recently serving as managing director and co-head of healthcare M&A at J.P. Morgan.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $187.70 | -0.69% | $2,96,601.39M | 17.35 | |
| $927.73 | +0.28% | $2,70,128.07M | 15.97 | |
| $89.47 | +0.80% | $1,54,723.69M | 20.07 | |
| $460.66 | +2.52% | $1,33,545.33M | 26.96 | |
| $296.42 | +0.81% | $1,06,097.91M | 24.24 | |
| $163.04 | +4.54% | $91,116.21M | 22.90 | |
| $488.83 | +2.42% | $84,274.29M | 32.67 | |
| $91.59 | +0.18% | $72,669.80M | 45.93 | |
| $105.60 | +0.05% | $58,604.09M | 28.95 | |
| $618.55 | +2.25% | $44,226.33M | 31.19 | |
| $81.77 | -2.12% | $37,048.19M | 38.02 | |
| $160.59 | -1.07% | $35,779.93M | - |
An investment of $100 made 5 years ago in Evercore - Class A is now worth
$ 189.15
giving a profit of
$ 89.15 (89.15%)
Note: Past profits do not guarantee future returns.
